explore -WSS

explore

author：leisure time 2025-10-01 12:11:50 - browse：68

Why are addiction treatments so hard to get? Can small companies compete in obesity? And since when is “Series E” a thing in biotech?

We cover all that and more this week on “The Readout LOUD,” STAT’s biotech podcast. For the entirety of the opioid overdose epidemic, the U.S. has had readily available tools that are proven to save lives. STAT’s Lev Facher joins us to explain his reporting on why virtually every sector of American society is standing in the way of their use. We also discuss the latest news in the life sciences, including the haves and have-nots of venture capital, and the race to develop effective oral treatments for obesity.

For more on what we cover, here’s the story on addiction medicine; here’s the latest on biotech financing; here’s more on Novo Nordisk’s oral obesity treatment; here’s where you can find episodes of Color Code; here’s where you can subscribe to the First Opinion Podcast; and here’s where you can subscribe to our biotech newsletter, The Readout.

Be sure to sign up on Apple Podcasts, Spotify, Stitcher, TuneIn, or wherever you get your podcasts.

And if you have any feedback for us — topics to cover, guests to invite, vocal tics to cease — you can email [email protected].

Previous article： Dobbs anniversary: the lost opportunity of abortion as health care
Next article： Flagship, Pfizer team up in deal worth up to $7 billion

WSS

15 die by electrocution after transformer explodes in northern India

Is mRNA technology the right fit for flu shots? Experts aren’t so sure

The EPA's new lead rule: How one expert crunched the numbers

UnitedHealth has 90,000 doctors — 10% of all physicians in U.S.

U.K. Biobank has 500,000 peoples' genome sequences available

UK homeowners get some respite as inflation falls by more than anticipated to a 15

focus

explore

knowledge

Hollywood unions extend contract negotiations for actors

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Alkermes shareholders re

Twill hunts for pharma partner to market its depression app

New air purifier tech could be key to improving indoor air quality

BIO selects John Crowley as new CEO

Continuity nursing helped my family in our darkest PICU moments

With clinical trial data readouts, here's how to spot spin

DIEP, the 'gold standard' of breast reconstruction, is under threat

With clinical trial data readouts, here's how to spot spin

hotspot

Diagnostic tests are hitting their mathematical limits

The EPA's new lead rule: How one expert crunched the numbers

FDA seeking to stop procedures at two unregulated stem cell clinics

Israeli protesters block highways, train stations as Netanyahu moves ahead with judicial overhaul

Britain’s MI6 chief says his spies are using AI to disrupt flow of weapons to Russia

A Theranos scientist

leisure time

knowledge

leisure time

explore